ALAM
ALNY icon

Asahi Life Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Asahi Life Asset Management’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$418K Buy
1,388
+305
+28% +$92K 0.24% 104
2026
Q1 		$358K Buy
1,083
+50
+5% +$17K 0.23% 93
2025
Q4 		$411K Sell
1,033
-10
-1% -$4.43K 0.23% 109
2025
Q3 		$476K Sell
1,043
-237
-19% -$96.5K 0.26% 73
2025
Q2 		$417K Sell
1,280
-160
-11% -$44.3K 0.24% 94
2025
Q1 		$389K Sell
1,440
-40
-3% -$10.3K 0.25% 98
2024
Q4 		$348K Sell
1,480
-120
-8% -$31.6K 0.21% 113
2024
Q3 		$440K Buy
+1,600
New +$417K 0.27% 84
2024
Q2 		– Sell
-2,150
Closed -$321K – 151
2024
Q1 		$321K Buy
+2,150
New +$359K 0.19% 139
2021
Q2 		– Sell
-2,610
Closed -$369K – 242
2021
Q1 		$369K Buy
+2,610
New +$393K 0.05% 158
2020
Q3 		– Sell
-2,380
Closed -$353K – 235
2020
Q2 		$353K Sell
2,380
-1,720
-42% -$232K 0.06% 110
2020
Q1 		$446K Buy
4,100
+920
+29% +$106K 0.08% 93
2019
Q4 		$366K Buy
+3,180
New +$317K 0.05% 158

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Asahi Life Asset Management's ALNY Position: Q2 2026 in Review

Asahi Life Asset Management increased its Alnylam Pharmaceuticals (ALNY) stake by 28% in Q2 2026, buying an estimated $92K and bringing the position to 1,388 shares worth $418K. The position accounts for 0.24% of the portfolio, ranked #104.

Asahi Life Asset Management first reported a position in ALNY in Q4 2019 and has held it in 13 quarters since. The position peaked at $476K in Q3 2025. 790 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Asahi Life Asset Management held 1,388 shares of Alnylam Pharmaceuticals worth $418K as of Q2 2026.
  • Asahi Life Asset Management bought 305 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $92K.
  • Alnylam Pharmaceuticals made up 0.24% of Asahi Life Asset Management's portfolio in Q2 2026, its #104 holding.
  • Asahi Life Asset Management first reported a position in Alnylam Pharmaceuticals in Q4 2019 and has held it in 13 quarters since.
  • Asahi Life Asset Management's Alnylam Pharmaceuticals position peaked at $476K in Q3 2025.
  • 790 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Asahi Life Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.